
News|Articles|February 13, 2019
Daurismo for Newly Diagnosed AML
Author(s)Drew Boxler
Advertisement
Daurismo (glasdegib, Pfizer)
Indications: Newly-diagnosed acute myeloid leukemia (AML) in adult patients who are 75 years old or older and have comorbidities that preclude use of intensive induction chemotherapy
Dosage: 100 mg orally, once daily.
Contraindications: None
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
From Policy to Practice: Elevating Pharmacy’s Role in Quality and Patient Safety
2
Trump Executive Order Set to Reclassify Marijuana, Improve CBD Access
3
Trial Approvals Face Delays During COVID-19 Pandemic
4
REM-Dominant Sleep Apnea Is Significantly More Prominent Following COVID-19
5

















































































































